| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |